Details for New Drug Application (NDA): 050011
✉ Email this page to a colleague
NDA 050011 describes PATHOCIL, which is a drug marketed by Wyeth Ayerst and is included in two NDAs. Additional details are available on the PATHOCIL profile page.
The generic ingredient in PATHOCIL is dicloxacillin sodium. There are nine drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the dicloxacillin sodium profile page.
The generic ingredient in PATHOCIL is dicloxacillin sodium. There are nine drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the dicloxacillin sodium profile page.
Summary for 050011
| Tradename: | PATHOCIL |
| Applicant: | Wyeth Ayerst |
| Ingredient: | dicloxacillin sodium |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 050011
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 500MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Mar 28, 1983 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
